Related Experiment Video
Updated: Aug 17, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
[Acute cerebral circulation problems]
P D Schellinger1, R Kollmar, U K Meyding-Lamadé
1Neurologische Klinik, Universitätsklinikum Heidelberg. Peter_Schellinger@med.uni-heidelberg.de
Insights
Acute stroke, a leading cause of death and disability, requires rapid intervention. Current treatments focus on restoring blood flow to the brain
Area of Science:
- Neurology
- Emergency Medicine
- Vascular Medicine
Context:
- Acute stroke is a major cause of death and permanent disability globally.
- Ischemic stroke results from cerebral artery occlusion, compromising brain perfusion (penumbra).
- Treatment strategies target reperfusion and neuroprotection of ischemic penumbral tissue.
Purpose:
- To outline current diagnostic and treatment paradigms for acute ischemic stroke.
- To emphasize the time-sensitive nature of stroke interventions.
- To discuss the role of neuroimaging and reperfusion therapies.
Summary:
- Diagnosis involves history, neurostatus, and imaging (CT/MRI) to rule out hemorrhage.
- Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is effective within 3-4.5 hours.
- Advanced therapies like mechanical reperfusion and hemicraniectomy are options for select severe cases, often in specialized centers.
Impact:
- Timely diagnosis and treatment significantly improve patient outcomes.
- Understanding the penumbra concept guides therapeutic decisions.
- Ongoing research aims to expand treatment windows and improve reperfusion techniques.
Abstract:
Acute stroke is the third most common cause of death and also the most common cause of permanent disability in industrialized countries. Ischemic stroke is caused by occlusion of a cerebral artery leading to a critical reduction in brain perfusion in the respective brain area (penumbra). Most acute stroke treatment strategies are based on the penumbra concept: attaining rapid and persistent reperfusion is followed by the protection of critically ischemic and not yet infarcted (penumbral) tissue by, e.g., neuroprotection. Examination of the acute stroke patient includes a brief history, neurostatus and imaging (CT or MRI) for the exclusion of intracerebral hemorrhage. The diagnostic standard is CT; modern stroke MRI protocols provide an improved selection in later time windows. Intravenous thrombolysis with rt-PA within 3 h of symptom onset is the only approved therapy with a proven significant benefit for the patient. The effect is smaller but still significant if treatment occurs up to 4.5 h, and may still be present in MRI selected patients up to 9 h. More aggressive forms of therapy include interventional reperfusion techniques and therapy of malignant MCA infarction such as hemicraniectomy and hypothermia, which at present, however, are not routine and are only performed in specialized centers.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Cerebral Edema ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Increased Intracranial Pressure ll: Pathophysiology

